Return to search

Clinical utility, cost-effectiveness and provider perceptions of CYP2C9 and VKORC1 genotyping for chronic warfarin therapy /

Thesis (Ph. D.)--University of Washington, 2008. / Vita. Includes bibliographical references (leaves 91-124).

Identiferoai:union.ndltd.org:OCLC/oai:xtcat.oclc.org:OCLCNo/239609869
Date January 2008
CreatorsMeckley, Lisa M.
Source SetsOCLC
LanguageEnglish
Detected LanguageEnglish
TypeTheses
SourceConnect to this title online; UW restricted

Page generated in 0.0014 seconds